How to Write a Science Immunology Cover Letter (With Template)

Science Immunology editors are scanning for signal density, not literary polish. Per the AAAS instructions for authors, the cover letter should carry the paper title and a statement of its main point, why the work is important, and why readers of the journal would be interested. Translate that into four moves in this order.

The order matters. A letter that names the advance, then the significance, then the fit, then the logistics is easier to triage and easier to route within the Science family.

AAAS requires an explicit non-duplication statement at submission. Put a line like this in the cover letter so the editor sees it during triage:

This manuscript is original, has not been published previously, and is not under consideration for publication elsewhere, including on the Internet. All authors have read and approved this submission.

That single sentence covers two required items: the not-published-or-under-consideration declaration and the all-authors-approved confirmation. The AAAS Science journals editorial policies also ask you to supply copies of any related papers under consideration or in press elsewhere, and to disclose them if a related paper is submitted while your Science Immunology manuscript is in review.

Science Immunology accepts several article types, and the cover-letter emphasis shifts with each.

For a Research Article, the letter must argue mechanism and breadth together. For a Report, lead with the single decisive finding and resist padding the significance paragraph. Naming the correct type in the first sentence ("We are submitting our Report...") tells the editor how to weigh the rest.

Beyond the non-duplication declaration, the AAAS submission system at AAAS journal page collects several items the cover letter should support or anticipate.

• Suggested reviewers. The AAAS instructions require five potential referees with names, affiliations, and email addresses. Choose people outside your institutions who can judge both the immunology mechanism and the broad significance. AAAS asks authors to keep gender and country-of-origin diversity in mind when listing referees.

• Excluded reviewers. You may exclude up to three reviewers.

Name them in the portal field, and keep any explanation brief and factual rather than accusatory.

• Competing interests. The AAAS editorial policies specify that every author must disclose affiliations, funding, and competing interests that could be perceived as a source of bias.

State "no competing interests" explicitly if that is the case.

• Related-manuscript and prior-discussion disclosure. Disclose any related manuscript submitted, in press, or under consideration elsewhere, and reference any pre-submission discussion you have had with an editor about this work.

• Preprint disclosure. If the work is on a preprint server, note it and link it. AAAS permits preprints under its policy, but the editor should not be surprised by one.

A clean declarations block signals a carefully prepared submission, which improves first-pass trust at triage.

Here is the part authors rarely picture. When we read a Science Immunology cover letter from the editorial side, we are not checking whether the science is correct yet. The Science-family editorial culture rewards breadth, so Science Immunology editors screen the opening sentence for a conceptual advance, then test the significance paragraph against one silent question: would an immunologist two subfields over care?

We are deciding, in the first minute, whether the paper is a broad immunology event or a specialist story that arrived at the wrong door. If the letter only argues importance within one technical niche, we are already weighing a transfer offer to a sister venue rather than a route to review. The declarations block tells us, in seconds, whether the submission was assembled with care or in a hurry.

In our pre-submission review work with Science Immunology submissions, four named desk-rejection patterns predict a desk outcome before the editor opens the manuscript file, even when the underlying immunology is rigorous. Each maps to a Science-family editorial triage pattern, and each is testable against your own letter right now.

The advance is real but framed too narrowly. The most common pattern we see in Science Immunology cover letters is a significance statement that argues importance only inside one specialist readership. The data may be excellent, but the letter never connects the result to a broad immunology consequence. Science Immunology routes papers by breadth, so a letter that reads as specialist-only is a transfer candidate, not a review candidate.

The fix is to name, in the significance paragraph, a second immunology subcommunity that would change how it thinks because of this conceptual advance. If you cannot name one honestly, the paper may belong at Nature Immunology or Immunity instead.

The phenotype outruns the mechanism in the letter. We repeatedly see Science Immunology cover letters that describe a striking immune phenotype while the mechanism sentence stays vague. Editors at this journal read a confident phenotype claim with no mechanistic anchor as a signal that the central story is not yet closed. The letter should state the mechanism in the same sentence as the advance, not defer it to the Results.

When the mechanism in the cover letter is thinner than the mechanism in the manuscript, you are underselling your own paper at the exact moment it is being triaged.

The abstract is pasted in place of an editorial argument. A large share of the Science Immunology letters we review restate the abstract, walking through background, methods, and results in the same order. That gives the editor no new signal. The abstract answers "what did you do?"; the cover letter has to answer "why should this be reviewed as a broad immunology advance?" If your letter and your abstract could be swapped without anyone noticing, the letter is not doing the editorial job Science Immunology needs.

The declarations and reviewer fields are an afterthought. We see otherwise strong Science Immunology submissions weakened by a missing non-duplication line, an empty competing interests statement, or suggested reviewers drawn entirely from one subfield. AAAS expects five referees and allows three exclusions, and a reviewer list confined to the authors' immediate community implicitly argues the paper is a specialist story.

Suggest at least one referee who can judge the broad significance, and make the declarations block explicit. A careless logistics section quietly tells the editor the science may have been prepared with the same haste.

These are all fixable before submission. A Science Immunology desk-rejection risk check evaluates whether your advance framing, mechanism statement, and declarations align with the editorial bar before you commit.

Science Immunology sits inside the AAAS Science family, and the editor reads your cover letter partly to decide where the paper belongs. A broadly significant immunology paper with reach beyond the field may draw a transfer offer to Science. A substantive but not flagship-level advance may be routed toward Science Advances, the family's gold open-access venue. A translational-dominant story may fit Science Translational Medicine better.

You can indicate openness to a Science-family transfer if your paper is not selected, which keeps your cascade plan inside one submission system rather than starting over elsewhere. Writing the cover letter to argue genuine breadth, rather than overclaiming flagship status, makes any transfer offer land on a stronger paper.

The fit sentence in your letter changes depending on the target, because each top immunology venue weighs significance differently. A Science Immunology editor wants broad immunology consequence the wider Science readership can absorb; a Nature Immunology editor (Nature Portfolio) wants a paradigm-defining mechanism; an Immunity editor (Cell Press) wants a full mechanistic causal chain in the Cell house style. The same paper, pitched to Science Immunology, Nature Immunology, and Immunity, needs three different fit sentences.

The practical read: if your strongest fit sentence is "complete causal chain," you may be writing an Immunity letter, not a Science Immunology one. Match the letter to the venue's actual editorial test.

We reviewed the AAAS instructions for Science Immunology research articles, the Science journals editorial policies, and the journal homepage, and we checked them against the patterns we see in our pre-submission review work with immunology submissions. We did not test a private AAAS submission account for this page; the requirements quoted here come from public AAAS materials, and the editorial framing comes from pre-submission review patterns.

Use this page when the question is the cover letter itself, before you submit. For upload mechanics, scope fit, and timing, use the Science Immunology submission guide; for the journal's standing, use the Science Immunology impact factor page.